Similarly, N-Myc recruits HDAC5 to the CD9 gene, repressing CD9 protein expression and decreasing CD9 glycoprotein content of the cell membrane, thereby increasing the degree of malignancy of clinical NB. The gene discussed is CD9; the disease is neuroblastoma.